Published in:
01-06-2020 | Insulins | Original Article
Association of PPARγ gene expression with postprandial hypertriglyceridaemia and risk of type 2 diabetes mellitus
Published in: Endocrine | Issue 3/2020
Login to get accessAbstract
Purpose
Peroxisome proliferator-activated receptor γ (PPARγ) gene is strongly associated with type 2 diabetes mellitus, as well as postprandial lipemia, and plays an important role in Wnt dependent adipogenesis in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). We aimed to study the expression of PPARγ gene in SAT and VAT to find out its correlation with postprandial hypertriglyceredemia and glucose intolerance.
Methods
Thirty subjects who were scheduled to undergo abdominal surgery were recruited in three groups (n = 10 in NGT, n = 10 in prediabetes, and n = 10 in T2DM). A standardized oral fat challenge was performed. Anthropometry, plasma glucose, HbA1c, and fasting serum insulin were also measured. SAT and VATs were collected during surgery for PPARγ gene expression studies by real-time PCR.
Results
PPARγ gene expression was 5.5-fold lower in T2DM and 1.7-fold lower in prediabetes as compared with NGT subjects in VAT. There was a significant negative correlation of expression of PPARγ gene in VAT {Tgauc (r = −0.57, p < 0.007), Peak Tg (r = −0.51, p < 0.01)} as well as in subcutaneous adipose tissue {Tgauc (r = −0.45, p < 0.02)} with PPTg responses measures.
Conclusion
Reduced adipocyte expression of PPARγ gene and the resultant postprandial hypertriglyceredemia is associated with greater risk of diabetes and prediabetes.